Original Research: A Patented Strain of Bacillus coagulans Increased Immune Response to Viral Challenge
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Viral respiratory tract infection is the most common illness among humans. Probiotics have been known to enhance the immune system and, therefore, may represent a significant therapeutic advancement for treating viral respiratory tract infections. OBJECTIVE: A controlled study was conducted to evaluate the effects of the patented GanedenBC30 probiotic (Bacillus coagulans GBI-30, 6086, marketed as Sustenex [Ganeden Biotech, Inc., Mayfield Heights, OH]) on the immune system when exposed to adenovirus and influenza in otherwise healthy adults. METHODS: Ten healthy men and women (average age, 44 years) were instructed to consume 1 capsule of GanedenBC30 with water once a day for 30 days. At baseline and after completion of the 30-day treatment, blood levels of cytokines were measured in vitro after T-cell exposure to adenovirus and influenza A. Each participant served as his/her own control with baseline blood draw. RESULTS: The use of GanedenBC30 significantly increased T-cell production of TNF-alpha in response to adenovirus exposure (P = 0.027) and influenza A (H3N2 Texas strain) exposure (P = 0.004), but it did not have a significant effect on the response to other strains of influenza. No serious adverse events were reported throughout the study. CONCLUSIONS: The patented GanedenBC30 probiotic may be a safe and effective therapeutic option for enhancing T-cell response to certain viral respiratory tract infections.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lactobacillus Sepsis Associated With Probiotic Therapy
Land, M. H., Rouster-Stevens, K., Woods, C. R., Cannon, M. L., Cnota, J., & Shetty, A. K. (2005) · Pediatrics · doi:10.1542/peds.2004-2137 · Cited by 599 · cited 1×
“Studies have shown that lactobacilli and bifi dobacteria may be associated with opportunistic infections such as bacteremia, sepsis, or endocarditis among immunocompromised patients.(12,13) The transience of GanedenBC(30) in the gut reduces the risk of developing pathogenesis-conferring mutations and causing infection…”
de Vrese, M., Winkler, P., Rautenberg, P., Harder, T., Noah, C., Laue, C., Ott, S., Hampe, J., Schreiber, S., Heller, K., et al. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.05.048 · Cited by 201 · cited 1×
“A more recent study investigating the effects of probiotic bacteria on viral respiratory tract infections found that lactobacilli and bifi dobacteria in tablet form had no effect on the incidence of colds, but did reduce the duration of episodes by almost 2 days.(16)”
Cited by
Cao, J., Yu, Z., Liu, W., Zhao, J., Zhang, H., Zhai, Q., & Chen, W. (2020) · Journal of Functional Foods · doi:10.1016/j.jff.2019.103643 · Cited by 254
A review of probiotic supplementation in healthy adults: helpful or hype?
Khalesi, S., Bellissimo, N., Vandelanotte, C., Williams, S., Stanley, D., & Irwin, C. (2019) · European Journal of Clinical Nutrition · doi:10.1038/s41430-018-0135-9 · Cited by 242
Human gut microbiota and its relationship to health and disease: Nutrition Reviews©, Vol. 69, No. 7
Wallace, T. C., Guarner, F., Madsen, K., Cabana, M. D., Gibson, G., Hentges, E., & Sanders, M. E. (2011) · Nutrition Reviews · doi:10.1111/j.1753-4887.2011.00402.x · Cited by 234
Structural Stability and Viability of Microencapsulated Probiotic Bacteria: A Review
Corona‐Hernandez, R. I., Álvarez‐Parrilla, E., Lizardi‐Mendoza, J., Islas‐Rubio, A. R., de la Rosa, L. A., & Wall‐Medrano, A. (2013) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.12030 · Cited by 216
Shinde, T., Hansbro, P. M., Sohal, S. S., Dingle, P., Eri, R., & Stanley, R. (2020) · Microorganisms · doi:10.3390/microorganisms8060921 · Cited by 61
“coagulans BC30 has been confirmed in ex vivo experiments to increase the T-cell production of TNF-α in response to specific adenovirus and influenza virus exposures [71].”
BackgroundWeizmannia coagulans: an Ideal Probiotic for Gut Health
Zhang, S., Li, P., Lee, S., Wang, Y., Tan, C., & Shang, N. (2023) · Food Science and Human Wellness · doi:10.26599/fshw.2022.9250002 · Cited by 18
Metadata
- Authors
- Baron, M.
- Venue
- Postgraduate Medicine
- Publisher
- Informa UK Limited
- Published
- 2009-03
- Volume
- 121
- Issue
- 2
- Pages
- 114-118
- ISSN
- 0032-5481 (ISSN-L)
- 1941-9260
- OpenAlex
- W1998151250
- Cited by
- 66
- References
- 2
- FWCI
- 4.57
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.